FDA
-
-
-
-
-
-
-
FDA approves Merck's Keytruda combo with Trodelvy for TNBC
-
-
-
-
-
-
-
U.S. FDA Approves an Additional Indication for CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) in Children and Adolescents Aged 2 through 17 at Increased Risk for Pneumococcal Disease
-
-
-
-
-
-
-
Apotex launches sitagliptin tablets and sitagliptin and metformin hydrochloride tablets, eligible for 180-day shared exclusivity
-
-
-
-
-
-
-
Merck Highlights New Long-Term Data and Advancements Across Broad Oncology Portfolio and Pipeline Research at ASCO 2026
-
-
-
-
-
-
-
Merck and Eisai report failed kidney cancer drug trial results
-
-
-
-
-
-
-
European Commission Approves Merck’s ENFLONSIA™ (clesrovimab) for the Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants During Their First RSV Season
-
-
-
-
-
-
-
Merck's WINREVAIR shows promise in heart failure trial
-
325,585 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

